Keene & Associates’s Avanos Medical AVNS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-18,165
| Closed | -$437K | – | 77 |
|
|
2024
Q3 | $437K | Sell |
18,165
-470
| -3% | -$11.3K | 0.33% | 55 |
|
|
2024
Q2 | $371K | Buy |
18,635
+2,585
| +16% | +$51.5K | 0.3% | 54 |
|
|
2024
Q1 | $320K | Buy |
16,050
+5,875
| +58% | +$117K | 0.24% | 68 |
|
|
2023
Q4 | $228K | Sell |
10,175
-3,500
| -26% | -$78.5K | 0.19% | 75 |
|
|
2023
Q3 | $277K | Buy |
13,675
+1,533
| +13% | +$31K | 0.22% | 68 |
|
|
2023
Q2 | $310K | Buy |
12,142
+475
| +4% | +$12.1K | 0.24% | 63 |
|
|
2023
Q1 | $347K | Buy |
+11,667
| New | +$347K | 0.27% | 56 |
|
|
2022
Q4 | – | Sell |
-11,917
| Closed | -$260K | – | 77 |
|
|
2022
Q3 | $260K | Buy |
11,917
+275
| +2% | +$6K | 0.24% | 64 |
|
|
2022
Q2 | $318K | Buy |
11,642
+1,132
| +11% | +$30.9K | 0.3% | 55 |
|
|
2022
Q1 | $352K | Buy |
10,510
+2,745
| +35% | +$91.9K | 0.29% | 57 |
|
|
2021
Q4 | $269K | Buy |
+7,765
| New | +$269K | 0.23% | 68 |
|